Daily Market Reports | Sep 15 2025
This story features 29METALS LIMITED, and other companies.
For more info SHARE ANALYSIS: 29M
An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities.
In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Australian Broker Call *Extra* Edition, featuring additional sources of research and insights on ASX-listed stocks, also enlarging the number of stocks that make up the FNArena universe.
One key difference is the *Extra* Edition will not be updated daily, but merely “regularly” depending on availability of suitable quality content. As such, the *Extra* Edition tries to build a bridge between daily updates via the Australian Broker Call Report and ad hoc news stories, that are not always timely for investors hungry for the next information update.
Investors using the *Extra* Edition as a source of input for their own share market research should thus take into account that information after publication may not be up to date, or yet awaiting another update by FNArena’s team of journalists.
Similar to The Australian Broker Call Report, this *Extra* Edition includes concise but limited reviews of research recently published by Stockbrokers and other experts, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end of this Report.
The Australian Broker Call *Extra* Edition is a summary that has been prepared independently of the sources identified. Readers will check the full text of the recommendations and consult a Licenced Advisor before making any investment decision.
The copyright of this Report is owned by the publisher. Readers will not copy, forward or disseminate this Report to any other person. For more vital information about the sources included, see the bottom of this Report.
COMPANIES DISCUSSED IN THIS ISSUE
Click on a symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)
29M AAR ALK BRU GBZ GNC JIN MIN ORE PLL PNR PYC RSG RXR SFR SIG SYA
29M 29METALS LIMITED
Copper – Overnight Price: $0.47
Jarden rates ((29M)) as Underweight (4) –
Jarden notes 29Metals’ operational inconsistency persists, with production from Golden Grove in 1H25 reaching only 41% of copper and 45% of zinc FY25 guidance midpoints.
A seismic event in the current quarter means achieving even the lower end of FY25 guidance will be challenging. As a result, the broker’s FY25 EBITDA forecast is -30% below consensus.
The broker notes headwinds from treatment and refining charges benefit copper exposure, but legacy punitive zinc contracts are constraining earnings.
Target unchanged at 30c. Rating retained at Underweight as the broker seeks greater operational consistency, de-watering progress, and positive free cash flow to become more constructive.
This report was published on September 8, 2025.
Target price is $0.30 Current Price is $0.47 Difference: minus $0.17 (current price is over target).
If 29M meets the Jarden target it will return approximately minus 36% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $0.25, suggesting downside of -47.3%(ex-dividends)
The company’s fiscal year ends in December.
Forecast for FY25:
Jarden forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 3.30 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 14.24.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 0.8, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 58.7.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 1.60 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 29.37.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is -0.3, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.
Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
AAR ASTRAL RESOURCES NL
Gold & Silver – Overnight Price: $0.19
Petra Capital rates ((AAR)) as Buy (1) –
Alongside the infill drilling program at its Mandilla gold project, Astral Resources is moving forward with exploration activities to achieve its definitive feasibility study by mid-2026, Petra Capital notes.
The analyst highlights the Maximus Resources acquisition added resources of 139koz as well as green and brownfield exploration potential.
The current mineral resource estimate for Spargoville global is 3Mt at 1.4g/t of Au for 139koz.
Buy rating and 35c target unchanged.
This report was published on September 9, 2025.
Target price is $0.35 Current Price is $0.19 Difference: $0.16
If AAR meets the Petra Capital target it will return approximately 84% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY25:
Petra Capital forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 0.30 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 63.33.
Forecast for FY26:
Petra Capital forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 0.40 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 47.50.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
ALK ALKANE RESOURCES LIMITED
Gold & Silver – Overnight Price: $1.03
Moelis rates ((ALK)) as Downgrade to Hold from Buy (3) –
Alkane Resources’ formal FY26 guidance following the merger completion with Mandalay Resources was a clear disappointment to Moelis.
The consolidated gold production guidance was lower than the broker’s estimate at the midpoint, but the bigger negative was a miss to Tomingley’s production forecast and higher costs.
Costs guidance for all three mines were higher than the broker’s forecast, but the combination of lower production surprised negatively.
The broker cut FY26 net profit forecast by -38% and FY27 by -31%, with similar downgrades to EPS forecasts.
Target trimmed to $1.20 from $1.40. Rating downgraded to Hold from Buy.
This report was published on September 10, 2025.
Target price is $1.20 Current Price is $1.03 Difference: $0.17
If ALK meets the Moelis target it will return approximately 17% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Moelis forecasts a full year FY26 dividend of 0.00 cents and EPS of 11.60 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 8.88.
Forecast for FY27:
Moelis forecasts a full year FY27 dividend of 0.00 cents and EPS of 11.40 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 9.04.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
BRU BURU ENERGY LIMITED
Crude Oil – Overnight Price: $0.02
Wilsons rates ((BRU)) as No Rating (-1) –
Buru Energy is part of Wilsons incubator product which highlights emerging growth companies for education purposes only. The stock is not rated.
The company is an oil and gas explorer focused on the Canning Basin, onshore WA, with the target of developing the flagship Rafael gas project.
A $2.1m placement has been completed with a $3m share purchase plan to fund Rafael, with estimated capital needs for development of -$40m, meaning additional funds will be needed.
Buru has also identified a new prospect, Flying Fox, beneath the Rafael field which is flagged as a potential step change, Wilsons highlights, and could double Buru’s energy resource if successful.
The stock is not rated.
This report was published on September 9, 2025.
Current Price is $0.02. Target price not assessed.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
GBZ GBM RESOURCES LIMITED
Gold & Silver – Overnight Price: $0.04
Canaccord Genuity rates ((GBZ)) as Initiation of coverage with Speculative Buy (1) –
Canaccord Genuity has initiated coverage of GBM Resources with a Speculative Buy rating and target price of 8c.
The broker highlights the company is a debt-free, well-funded ($6m cash) gold explorer in Queensland’s Drummond Basin. The company holds a 1.84Moz gold resource and is targeting over 3Moz within 12–18 months.
Twin Hills (1Moz) is the flagship, with a 9,510m drill program underway and first assays due in October. Resource update is expected in 2H26.
Yandan offers high-grade feeder zone potential, while Mt Coolon provides leverage via a Newmont Mining ((NEM)) farm-in.
The broker’s net valuation is based on an unfunded scenario but acknowledges additional funds will likely be required in 2H26.
This report was published on September 9, 2025.
Target price is $0.08 Current Price is $0.04 Difference: $0.04
If GBZ meets the Canaccord Genuity target it will return approximately 100% (excluding dividends, fees and charges).
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
GNC GRAINCORP LIMITED
Agriculture – Overnight Price: $8.55
Wilsons rates ((GNC)) as Overweight (1) –
The September Abares report forecasts a rise in the 2025/26 ECA winter crop to 30mt, up 11% on the previous estimate, but remains under the prior season by -6% and above the 25-year historical average by circa 56%, Wilsons explains.
The improvement in winter crop expectations results in the analyst lifting GrainCorp’s FY26 earnings (EBITDA) forecasts by 22% and FY27 by 10% as some of the additional volumes from FY26 are flagged to move into FY27.
Overweight rating retained. Target price rises to $9.05 from $8.91.
This report was published on September 9, 2025.
Target price is $9.05 Current Price is $8.55 Difference: $0.5
If GNC meets the Wilsons target it will return approximately 6% (excluding dividends, fees and charges).
Current consensus price target is $9.00, suggesting upside of 5.3%(ex-dividends)
The company’s fiscal year ends in September.
Forecast for FY25:
Wilsons forecasts a full year FY25 dividend of 48.00 cents and EPS of 34.00 cents.
At the last closing share price the estimated dividend yield is 5.61%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 25.15.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 39.8, implying annual growth of 43.9%.
Current consensus DPS estimate is 43.8, implying a prospective dividend yield of 5.1%.
Current consensus EPS estimate suggests the PER is 21.5.
Forecast for FY26:
Wilsons forecasts a full year FY26 dividend of 54.00 cents and EPS of 59.00 cents.
At the last closing share price the estimated dividend yield is 6.32%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 14.49.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 49.4, implying annual growth of 24.1%.
Current consensus DPS estimate is 41.6, implying a prospective dividend yield of 4.9%.
Current consensus EPS estimate suggests the PER is 17.3.
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
JIN JUMBO INTERACTIVE LIMITED
Gaming – Overnight Price: $11.39
Wilsons rates ((JIN)) as Overweight (1) –
Jumbo Interactive has converted its reseller deal with RSL Queensland into a full five-year white-labelled SaaS agreement, commencing in 2Q FY27, with options for a further six years, Wilsons notes.
The RSL Lottery is Australia’s largest prize home lottery, generating around $200m annually in ticket sales, and will now run entirely on Jumbo’s Powered by Jumbo platform, highlights the broker.
The analyst forecasts the deal will lift group earnings (EBITDA) and profit by 3% in FY27 and 4% in FY28, reflecting SaaS revenue and earnings increases of 6% and 8%, respectively. Forecasts assume a flat revenue/TTV of 2.25% and 75% incremental earnings margin.
Wilsons points to Mater Foundation’s growth and the likely conversion of Yourtown (one of Australia’s largest charity art union lotteries) to full SaaS as providing further upside.
The broker raises its target price to $14.23 from $13.99 and retains an Overweight rating.
This report was published on September 9, 2025.
Target price is $14.23 Current Price is $11.39 Difference: $2.84
If JIN meets the Wilsons target it will return approximately 25% (excluding dividends, fees and charges).
Current consensus price target is $13.00, suggesting upside of 14.1%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Wilsons forecasts a full year FY26 dividend of 52.40 cents and EPS of 69.80 cents.
At the last closing share price the estimated dividend yield is 4.60%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 16.32.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 71.5, implying annual growth of 11.5%.
Current consensus DPS estimate is 54.5, implying a prospective dividend yield of 4.8%.
Current consensus EPS estimate suggests the PER is 15.9.
Forecast for FY27:
Wilsons forecasts a full year FY27 dividend of 60.80 cents and EPS of 81.00 cents.
At the last closing share price the estimated dividend yield is 5.34%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 14.06.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 81.6, implying annual growth of 14.1%.
Current consensus DPS estimate is 63.1, implying a prospective dividend yield of 5.5%.
Current consensus EPS estimate suggests the PER is 14.0.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
MIN MINERAL RESOURCES LIMITED
Iron Ore – Overnight Price: $37.45
Jarden rates ((MIN)) as Sell (5) –
Mineral Resources cleared the decks with an FY25 net loss of -$904m, and Jarden asks “where to next?”
The broker stresses the importance of Onslow’s ramp-up and resilient iron ore prices, noting the Chair sees no present need to raise equity but is exploring inorganic deleveraging opportunities.
Onslow shipped 2.33mt in July and 3.24mt in August, with Jarden lifting its September quarter forecast to 8.5mt and FY26 to 33.5mt, above guidance of 30–33mt.
Haul road repairs due in late September and delivery of the final trucks are expected to allow the removal of contractors and reduce costs.
Despite this, Jarden forecasts FY26 free cash flow of around -$500m, with net debt rising to $5.55bn, highlighting breakeven requires SC6 at circa US$1,350/t if iron ore stays at US$100/t.
Debt refinancing of US$700m notes due 2027 is expected soon, while Wodgina is viewed as the most likely asset sale candidate, worth about $1.57bn for the company’s stake.
Jarden maintains a Sell rating, citing lack of valuation support and no de-gearing progress in FY26. The target rises to $15.00 from $14.80.
This report was published on September 9, 2025.
Target price is $15.00 Current Price is $37.45 Difference: minus $22.45 (current price is over target).
If MIN meets the Jarden target it will return approximately minus 60% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $36.15, suggesting downside of -3.5%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 0.00 cents and EPS of 2.30 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 1628.26.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 49.2, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 76.1.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 0.00 cents and EPS of minus 72.70 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 51.51.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 118.3, implying annual growth of 140.4%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 31.7.
Market Sentiment: 0.1
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
ORE OREZONE GOLD CORPORATION REGISTERED
Gold & Silver – Overnight Price: $1.34
Canaccord Genuity rates ((ORE)) as Buy (1) –
An August site visit by Canaccord Genuity to Orezone Gold’s Bombore gold project located in central Burkina Faso. reinforced the analysts’ confidence in staged hard rock expansions.
The broker forecasts production will rise to 175koz in 2026 from 124koz in 2025, with Stage 1, and to 233koz in 2027 with Stage 2.
Construction is well advanced, note the analysts with Stage 1 plant 67% complete and on track for first gold in December, while Stage 2 procurement and engineering are progressing ahead of late-2026 commissioning.
Exploration upside remains strong along the 14km trend, according to the broker, with a resource update expected in early 2026.
Canaccord highlights Orezone Gold’s valuation is well below peers. A government statement confirming state equity increases are optional is seen as constructive. The broker reiterates a Buy rating with a $2.50 target price.
This report was published on September 8, 2025.
Target price is $2.50 Current Price is $1.34 Difference: $1.16
If ORE meets the Canaccord Genuity target it will return approximately 87% (excluding dividends, fees and charges).
The company’s fiscal year ends in December.
Forecast for FY25:
Canaccord Genuity forecasts a full year FY25 EPS of 18.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 7.44.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 EPS of 29.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 4.62.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
PLL PIEDMONT LITHIUM INC
New Battery Elements – Overnight Price: $0.14
Canaccord Genuity – Cessation of coverage
This report was published on September 9, 2025.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
PNR PANTORO GOLD LIMITED
Gold & Silver – Overnight Price: $5.37
Canaccord Genuity rates ((PNR)) as Speculative Buy (1) –
Canaccord Genuity raises its target forPantoro Gold to $5.45 from $3.75 after including the Mainfield mine, a part of the central historic gold mining centre of the company’s 100%-owned Norseman Gold Project.
Drilling via the Bullen decline will commence this quarter, note the analysts, aiming to establish a Reserve to support mining from FY27.
Initial production is expected that year with a greater than 600ktpa run rate by FY30, lifting the broker’s FY27 and FY28 production forecasts by 25% to 123koz and 149koz, respectively, and FY29-30 by 52% to 165kozpa.
The Speculative Buy rating is maintained.
This report was published on September 8, 2025.
Target price is $5.45 Current Price is $5.37 Difference: $0.08
If PNR meets the Canaccord Genuity target it will return approximately 1% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY25:
Canaccord Genuity forecasts a full year FY25 dividend of 0.00 cents and EPS of 22.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 24.41.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of 44.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 12.20.
Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
PYC PYC THERAPEUTICS LIMITED
Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $1.22
Canaccord Genuity rates ((PYC)) as Buy (1) –
Canaccord Genuity believes the next six months could be transformational for PYC Therapeutics.
The broker cites positive early safety and efficacy data from the autosomal dominant polycystic kidney disease (ADPKD) and autosomal dominant optic atrophy (ADOA) programs.
Early readouts in nine patients given PYC-001 in ADOA showed encouraging signals of disease stabilisation and some visual acuity gains, note the analysts.
The study is expected to transition to a multiple ascending dose trial in late 2025, laying the foundation for a pivotal Phase 2/3 program with efficacy data in 2026 to inform design and regulatory strategy.
ADPKD remains the largest contributor to valuation, with PYC-003 showing positive safety data and first patient results due December 2025, followed by repeat-dose efficacy data in early 2026, representing a key value inflection.
Bell Potter makes modest near-term forecast changes for R&D spend and lifts its price target to $2.85 from $2.40. The broker maintains a Buy rating.
This report was published on September 8, 2025.
Target price is $2.85 Current Price is $1.22 Difference: $1.63
If PYC meets the Canaccord Genuity target it will return approximately 134% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 13.60 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 8.97.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of minus 18.80 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 6.49.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
RSG RESOLUTE MINING LIMITED
Gold & Silver – Overnight Price: $0.89
Canaccord Genuity rates ((RSG)) as Buy (1) –
Resolute Mining’s Doropo gold project saw an upgrade in resource to 114Mt, a 28% increase vs the 2023 mineral resource estimate.
Canaccord Genuity notes an updated definitive feasibility study is due in the December quarter, expecting it to include a higher gold price assumption of US$1,950/oz vs US$1,450/oz. This is expected to support a longer mine life vs 10 years in the previous DFS.
The broker extended the mine life in its model to 2042 from 2037, with revised capex of -US$430m and life-of-mine cost of US$1,329/oz.
Buy. Target rises to $1.60 from $1.50.
This report was published on September 8, 2025.
Target price is $1.60 Current Price is $0.89 Difference: $0.71
If RSG meets the Canaccord Genuity target it will return approximately 80% (excluding dividends, fees and charges).
The company’s fiscal year ends in December.
Forecast for FY25:
Canaccord Genuity forecasts a full year FY25 dividend of 0.00 cents and EPS of 13.96 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 6.38.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of 21.71 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 4.10.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
RXR ROBEX RESOURCES INC
Gold & Silver – Overnight Price: $4.30
Canaccord Genuity rates ((RXR)) as Speculative Buy (1) –
Robex Resources is advancing construction of the Kiniero Gold Project in Guinea, with Bell Potter noting first gold remains on track for the December quarter of 2025.
Concrete works are nearly complete, notes the broker, both carbon-in-leach (CIL) tank trains are finished, and structural, mechanical and piping works are 22% complete.
The analysts note mine development is progressing with most of the fleet delivered and drilling at Sabali nearing completion.
Funding is underpinned by a US$130m Sprott facility, with further drawdowns expected and US$15m placed in escrow pending the Mansounia permit.
Canaccord raises its target price to $5.70 from $5.50 and maintains a Speculative Buy rating.
This report was published on September 8, 2025.
Target price is $5.70 Current Price is $4.30 Difference: $1.4
If RXR meets the Canaccord Genuity target it will return approximately 33% (excluding dividends, fees and charges).
The company’s fiscal year ends in December.
Forecast for FY25:
Canaccord Genuity forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 0.15 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 2866.67.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of 1.54 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 279.22.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
SFR SANDFIRE RESOURCES LIMITED
Copper – Overnight Price: $12.47
Jarden rates ((SFR)) as Neutral (3) –
Jarden is weighing what the next steps might be for Sandfire Resources following net debt reduction in FY25 and the forecast for net cash position by the end of 2025.
In the near to medium term, the broker will be watching production outcome for the September quarter, given it has been flagged as the weakest for FY26. The company’s management of cost inflation at Motheo and Matsa will be crucial too.
The broker sees upside from silver, where spot prices are near record highs. Limited opportunities are seen for dividends due to franking credit balance of only US$262m, which could mean scope for potential buybacks or growth via investments.
Neutral. Target unchanged at $11..
This report was published on September 9, 2025.
Target price is $11.00 Current Price is $12.47 Difference: minus $1.47 (current price is over target).
If SFR meets the Jarden target it will return approximately minus 12% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $12.00, suggesting downside of -3.8%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 6.20 cents and EPS of 68.23 cents.
At the last closing share price the estimated dividend yield is 0.50%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 18.28.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 64.7, implying annual growth of N/A.
Current consensus DPS estimate is 7.5, implying a prospective dividend yield of 0.6%.
Current consensus EPS estimate suggests the PER is 19.3.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 32.56 cents and EPS of 71.79 cents.
At the last closing share price the estimated dividend yield is 2.61%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 17.37.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 80.0, implying annual growth of 23.6%.
Current consensus DPS estimate is 20.1, implying a prospective dividend yield of 1.6%.
Current consensus EPS estimate suggests the PER is 15.6.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: -0.1
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
SIG SIGMA HEALTHCARE LIMITED
Health & Nutrition – Overnight Price: $3.00
Jarden rates ((SIG)) as Overweight (2) –
In an ongoing research deep dive on Sigma Healthcare, Jarden suggests Chemist Warehouse is well placed for global expansion, with a $330bn market opportunity across Ireland, the UK, Middle East and North Africa (MENA) and Europe.
The broker values offshore at 63c a share (19% of the unchanged $3.40 target) but notes potential to exceed $6.00 if Chemist Warehouse reaches 3% share, or around 2,800 stores, generating $10.4bn in sales.
Early success in Ireland and the UAE supports the model, with stores priced -29–33% below rivals. The UK offers a large $83bn total addressable market (TAM) and lacks a discounter model, highlight the analysts.
The MENA region also provides strong growth drivers, according to Jarden. Spain and Italy present nearer-term opportunities in Europe, with Germany and France longer dated.
Jarden retains an Overweight rating.
This report was published on September 9, 2025.
Target price is $3.40 Current Price is $3.00 Difference: $0.4
If SIG meets the Jarden target it will return approximately 13% (excluding dividends, fees and charges).
Current consensus price target is $3.06, suggesting upside of 1.9%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 3.60 cents and EPS of 6.00 cents.
At the last closing share price the estimated dividend yield is 1.20%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 50.00.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 6.2, implying annual growth of 22.5%.
Current consensus DPS estimate is 3.9, implying a prospective dividend yield of 1.3%.
Current consensus EPS estimate suggests the PER is 48.4.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 4.30 cents and EPS of 7.20 cents.
At the last closing share price the estimated dividend yield is 1.43%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 41.67.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 7.3, implying annual growth of 17.7%.
Current consensus DPS estimate is 4.5, implying a prospective dividend yield of 1.5%.
Current consensus EPS estimate suggests the PER is 41.1.
Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
SYA SAYONA MINING LIMITED
New Battery Elements – Overnight Price: $0.02
Canaccord Genuity rates ((SYA)) as Upgrade to Buy from Speculative Buy (1) –
Canaccord Genuity has resumed coverage of Sayona Mining following its merger with Piedmont Lithium. The company will be renamed Elevra Lithium.
The broker notes the North American Lithium (NAL) spodumene mine in Quebec delivered 205kt in FY25 at -US$778/t cash costs, versus 158kt at US$1,080/t in FY24. The analysts model output of 208ktpa at US$870/t over FY26-28.
At current prices, Canaccord points out NAL is near breakeven, while expansion to 300ktpa from FY29 could reduce costs by around -15% to -US$735/t, supporting a clear economic case.
The broker highlights optionality from Moblan, a 27-year, 300ktpa project with reserves upgraded following recent drilling, and Ewoyya in Ghana, where Elevra can earn 50% with offtake rights. Both are seen as high-quality longer-term development opportunities.
Canaccord lifts its valuation to 6c from 4c a share and upgrades to Buy from Speculative Buy.
This report was published on September 9, 2025.
Target price is $0.06 Current Price is $0.02 Difference: $0.04
If SYA meets the Canaccord Genuity target it will return approximately 200% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of 0.00 cents.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of 0.00 cents.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
Disclaimer:
The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don’t have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide experienced, intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface.
This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.
Click to view our Glossary of Financial Terms
CHARTS
For more info SHARE ANALYSIS: 29M - 29METALS LIMITED
For more info SHARE ANALYSIS: AAR - ASTRAL RESOURCES NL
For more info SHARE ANALYSIS: ALK - ALKANE RESOURCES LIMITED
For more info SHARE ANALYSIS: BRU - BURU ENERGY LIMITED
For more info SHARE ANALYSIS: GBZ - GBM RESOURCES LIMITED
For more info SHARE ANALYSIS: GNC - GRAINCORP LIMITED
For more info SHARE ANALYSIS: JIN - JUMBO INTERACTIVE LIMITED
For more info SHARE ANALYSIS: MIN - MINERAL RESOURCES LIMITED
For more info SHARE ANALYSIS: NEM - NEWMONT CORPORATION REGISTERED
For more info SHARE ANALYSIS: ORE - OREZONE GOLD CORPORATION REGISTERED
For more info SHARE ANALYSIS: PNR - PANTORO GOLD LIMITED
For more info SHARE ANALYSIS: PYC - PYC THERAPEUTICS LIMITED
For more info SHARE ANALYSIS: RSG - RESOLUTE MINING LIMITED
For more info SHARE ANALYSIS: RXR - ROBEX RESOURCES INC
For more info SHARE ANALYSIS: SFR - SANDFIRE RESOURCES LIMITED
For more info SHARE ANALYSIS: SIG - SIGMA HEALTHCARE LIMITED